Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06439953 · ClinicalTrials.gov registry record · NA

Irrisept Solution for Instrumented Spine Surgery

A NA study of Surgical Site Infection and Spine Surgery, sponsored by Rhode Island Hospital.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06439953: Recruiting NA study of Surgical Site Infection and Spine Surgery, sponsored by Rhode Island Hospital.

NCT06439953 is a NA study of Surgical Site Infection and Spine Surgery that is actively recruiting participants, run by Rhode Island Hospital. The registered enrollment target is 200 participants, below the 560-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06439953, a NA study of Surgical Site Infection and Spine Surgery, is actively recruiting participants, sponsored by Rhode Island Hospital.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

Various spine surgeons perform wound irrigation using saline mixed with vancomycin, relying on mechanical debridement of non-viable tissue, physical disruption of biofilm, and bacteriostatic effect against gram positive flora. When used as a powder, topical application of vancomycin has demonstrated increased risk of symptomatic seroma formation, which is an adverse outcome that often requires bedside or intra-operative aspiration. Broad-spectrum antiseptic agents, such as Irrisept, offer bacteriocidal properties to eliminate hardware inoculation, thereby minimizing the risk of deep space infection, while obviating the risk of seroma development.

Primary Outcome

Development of infection after index spinal instrumentation

Interventions

  • DRUG Vancomycin
  • DEVICE Chlorhexidine gluconate solution

Study Locations (1)

Rhode Island

  • Rhode Island Hospital - Providence

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-10-01
Est. Completion 2026-09-30
Phase NA
Rhode Island Hospital

130 total trials

What NCT06439953 shows while recruiting

NCT06439953 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 560-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (64% lower).

The record links to 8 conditions, with Surgical Site Infection appearing as the primary indexed condition, and to 2 interventions - of which Vancomycin is the first listed.

NCT06439953 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT06439953 about?

NCT06439953 is a clinical study titled "Irrisept Solution for Instrumented Spine Surgery". Various spine surgeons perform wound irrigation using saline mixed with vancomycin, relying on mechanical debridement of non-viable tissue, physical disruption of biofilm, and bacteriostatic effect against gram positive flora. When used as a powder, topical application of vancomycin has demonstrated...

What is the current status of trial NCT06439953?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-10-01. Estimated completion is 2026-09-30.

What conditions does trial NCT06439953 study?

This clinical trial studies the following conditions: Surgical Site Infection, Spine Surgery, Post-Op Complication, Site Infection, Spinal Instrumentation.

What interventions are being tested in trial NCT06439953?

The interventions under investigation include: Vancomycin (DRUG), Chlorhexidine gluconate solution (DEVICE).

Who is sponsoring clinical trial NCT06439953?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06439953 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgical Site Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06439953's enrollment target sits among peer trials

200 16th of 25 higher than 10 of 25 other Surgical Site Infection trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgical Site Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06439953, the US trial registry maintained by the National Library of Medicine. NCT06439953 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.